
### [NCIT:C7224](http://purl.obolibrary.org/obo/NCIT_C7224)
**Label:** Plasmablastic Lymphoma

**Subclasses:** [NCIT:C38159](http://purl.obolibrary.org/obo/NCIT_C38159) (Plasmablastic Lymphoma of Mucosa Site), [NCIT:C45216](http://purl.obolibrary.org/obo/NCIT_C45216) (Primary Cutaneous Plasmablastic Lymphoma), [NCIT:C80290](http://purl.obolibrary.org/obo/NCIT_C80290) (Plasmablastic Lymphoma of the Oral Mucosa), 

**Class expressions from DL-Learner:**

- [UBERON:0000167](http://purl.obolibrary.org/obo/UBERON_0000167) (oral cavity) 62.50%
- [NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast) 62.50%
- Thing 51.63%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40214](http://purl.obolibrary.org/obo/NCIT_C40214) (Cervical Large Cell Neuroendocrine Carcinoma))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40209](http://purl.obolibrary.org/obo/NCIT_C40209) (Cervical Glandular Dysplasia))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40208](http://purl.obolibrary.org/obo/NCIT_C40208) (Cervical Villoglandular Adenocarcinoma))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40206](http://purl.obolibrary.org/obo/NCIT_C40206) (Cervical Mucinous Adenocarcinoma, Minimal Deviation Type))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40205](http://purl.obolibrary.org/obo/NCIT_C40205) (Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 47.86%


